A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
Clinical trial NCT06703177 · RECRUITING
Trial details
- NCT number
- NCT06703177
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-18
- Primary completion
- 2026-01-01
- Enrollment
- 876
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.